A total of 90% of EGFR mutant NSCLC patients were with TTF-1 positive expression, indicating that TTF-1 had high sensitivity and negative predictive value (NPV) for EGFR mutation (90% and 87%, respectively). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.